StockData
Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc. (DYN) income statement

DYNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$15.87−0.15 (-0.94%)

Close on Nov 18, 2026Market cap $2.96BP/E –Yield –

See a number that looks wrong?